Skip to main content
. 2023 Aug 3;10:1175246. doi: 10.3389/fcvm.2023.1175246

Figure 5.

Figure 5

Kaplan–Meier survival analysis of 3-year survival after TAVR with SEV and BEV in the matched cohort (p = 0.9).